FDA approves first treatment for thyroid eye disease

3 months ago 12
The U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the attraction of thyroid oculus illness (TED). Approval was granted to Viridian Therapeutics.
Read Entire Article